Antipsychotic drugs

Faigel, 1995, Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance, Am J Gastroenterol, 90, 822 Di Salvo, 1995, Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients, Clin Cardiol, 18, 285, 10.1002/clc.4960180512 Dolan, 1995, Neuroleptic induced sudden death a case report and critical review, Med Sci Law, 35, 169, 10.1177/002580249503500212 Verdoux, 1995, Neuroleptic effects on neuropsychological test performance in schizophrenia, Schizophr Res, 14, 133, 10.1016/0920-9964(94)00018-4 King, 1995, Antipsychotic drug-induced dysphoria, Br J Psychiatry, 167, 480, 10.1192/bjp.167.4.480 Ebadi, 1995, Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders, Pharmacol Rev, 47, 575 Spila-Alegiani, 1995, Anticholinergic antiparkinsonian therapy in outpatients treated with neuroleptic drugs: a prescription survey, Eur J Clin Pharmacol, 48, 513, 10.1007/BF00194343 Avorn, 1995, Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study, Am J Med, 99, 48, 10.1016/S0002-9343(99)80104-1 Playford, 1995, Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs, J Neurol Neurosurg Psychiatry, 58, 487, 10.1136/jnnp.58.4.487 Shader, 1995, Case 5: the dextral dodder, J Clin Psychopharmacol, 15, 232, 10.1097/00004714-199506000-00019 Mazure, 1995, Assessment of extrapyramidal symptoms during acute neuroleptic treatment, J Clin Psychiatry, 56, 94 Gall, 1995, Death due to benzhexol toxicity, Forensic Sci Int, 71, 9, 10.1016/0379-0738(94)01607-7 Gold, 1995, Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence, J Clin Psychiatry, 56, 476 Sachdev, 1995, The epidemiology of drug-induced akathisia: Part I. Acute akathisia, Schizophr Bull, 21, 431, 10.1093/schbul/21.3.431 Baldessarini, 1985, Clinical and epidemiologic aspects of tardive dyskinesia, J Clin Psychiatry, 46, 8 Chatterjee, 1995, Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients, Am J Psychiatry, 152, 1724, 10.1176/ajp.152.12.1724 Dorevitch, 1995, Antipsychotic drugs and tardive dyskinesia: preliminary results in an adolescent psychiatric ward, J Clin Pharmacol Ther, 20, 63, 10.1111/j.1365-2710.1995.tb00630.x Pourcher, 1995, Neuroleptic associated tardive dyskinesias in young people with psychoses, Br J Psychiatry, 166, 768, 10.1192/bjp.166.6.768 Jeste, 1995, Risk of tardive dyskinesia in older patients, Arch Gen Psychiatry, 52, 756, 10.1001/archpsyc.1995.03950210050010 Goff, 1995, Tardive dyskinesia and substrates of energy metabolism in CSF, Am J Psychiatry, 152, 1730, 10.1176/ajp.152.12.1730 Sweet, 1995, Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life, Arch Gen Psychiatry, 52, 478, 10.1001/archpsyc.1995.03950180064009 Hegerl, 1995, Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?, Acta Psychiatr Scand, 91, 120, 10.1111/j.1600-0447.1995.tb09751.x Hayashi, 1995, Usage and side effects of neuroleptics in elderly Japanese patients, Am J Geriatr Psychiatry, 3, 308, 10.1097/00019442-199503040-00005 Arthur, 1995, Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia, J Clin Psychopharmacol, 15, 211, 10.1097/00004714-199506000-00010 Fève, 1995, Laryngeal tardive dyskinesia, J Neurol, 242, 455, 10.1007/BF00873549 Kruk, 1995, Neuroleptic-induced respiratory dyskinesia, J Neuropsychiatry Clin Neurosci, 7, 223, 10.1176/jnp.7.2.223 Hyde, 1995, Diurnal variation in tardive dyskinesia, Psychiatry Res, 56, 53, 10.1016/0165-1781(94)02662-3 Schwarta, 1995, Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment, J Clin Psychiatry, 56, 212 Silver, 1995, No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type invonluntary movements: a double-blind crossover, placebo-controlled study in mediated chronic schizophrenic patients, J Clin Psychiatry, 56, 167 Freudenreich, 1995, Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics, J Clin Psychiatry, 56, 173 Raja, 1995, Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients, Eur Arch Psychiatry Clin Neurosci, 245, 145, 10.1007/BF02193087 Keck, 1995, Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?, J Neuropsychiatry Clin Neurosci, 7, 135, 10.1176/jnp.7.2.135 Arfai, 1995, Experience with eleven cases of neuroleptic malignant syndrome, Iran J Med Sci, 20, 38 Shintani, 1995, Hyperventilation alternating with apnea in neuroleptic malignant syndrome associated with metoclopramide and cisapride, J Neurol Sci, 128, 232, 10.1016/0022-510X(94)00255-M Ram, 1995, Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome, Am J Med Genet Neuropsychiatry Genet, 60, 228, 10.1002/ajmg.1320600311 Fava, 1995, Neuroleptic malignant syndrome and lithium carbonate, J Psychiatry Neurosci, 20, 305 Rother, 1995, Polytrauma und malignes neuroleptisches Syndrom. Kasuistische Darstellung diagnostischer Probleme, Anästhesiol Internsivmed Notf Med Schmerzther, 30, 455, 10.1055/s-2007-996528 Burke, 1995, Neuroleptic malignant syndrome in a trauma patient, J Trauma, 39, 796, 10.1097/00005373-199510000-00038 Velamoor, 1995, Management of suspected neuroleptic malignant syndrome, Can J Psychiatry, 40, 545, 10.1177/070674379504000907 Baker, 1995, Further study of neuroleptic malignant syndrome, Am J Psychiatry, 152, 1831, 10.1176/ajp.152.12.1831a Dent, 1995, Catatonic syndrome following recovery from neuroleptic malignant syndrome, J Intell Disabil Res, 39, 457, 10.1111/j.1365-2788.1995.tb00553.x Terlikowska, 1995, Roznicowanie miedzy ostra smiertelna katatonia i zlosliwym zespolem neuroleptycznym, Opis przypadku. Psychiatr Pol, 29, 343 Dammers, 1995, Malignes neuroleptisches Syndrom, Dtsch Med Wochenschr, 120, 1739, 10.1055/s-2008-1055536 Longhurst, 1995, Neuroleptic malignant syndrome, Br J Psychiatry, 166, 537, 10.1192/bjp.166.4.537 Mesejo, 1995, Síndrome neuroléptico maligno, fallo multiorgánico y polineuropatía periférica, Rev Neurol, 23, 136 Guadagnucci, 1995, Sindrome maligna da neurolettici, Minerva Med, 86, 327 Spigset, 1995, Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs, Drug Saf, 12, 209, 10.2165/00002018-199512030-00006 Wesselmann, 1995, Galactorrhea: subjective response by schizophrenic patients, Acta Psychiatr Scand, 91, 152, 10.1111/j.1600-0447.1995.tb09758.x Stanton, 1995, Weight gain associated with neuroleptic medication: a review, Schizophr Bull, 21, 463, 10.1093/schbul/21.3.463 Holt, 1995, Hepatotoxicity of anesthetics and other central nervous system drugs, Gastroenterol Clin North Am, 24, 853, 10.1016/S0889-8553(21)00231-4 Ausseur, 1995, Entérocolite aiguë nécrosante au cours d'un traitement prolongé par neuroleptiques, Presse Méd, 24, 577 Hay, 1995, Complications at site of injection of depot neuroleptics, Br Med J, 311, 421, 10.1136/bmj.311.7002.421 Faucher, 1995, What syndrome is this? Nicolau syndrome, Pediatr Dermatol, 12, 187, 10.1111/j.1525-1470.1995.tb00151.x Hatton, 1995, Ulcerative skin reaction from subcutaneous infusion of isotonic methotrimeprazine and diamorphine, Clin Oncol, 7, 268, 10.1016/S0936-6555(05)80619-3 Marsh, 1995, Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy, Renal Fail, 17, 475, 10.3109/08860229509037611 Aizenberg, 1995, Sexual dysfunction in male schizo-phrenic patients, J Clin Psychiatry, 56, 137 Schiavi, 1990, Healthy aging and male sexual function, Am J Psychiatry, 147, 766, 10.1176/ajp.147.6.766 Malt, 1995, Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients, Br J Psychiatry, 166, 374, 10.1192/bjp.166.3.374 De Leon, 1995, Schizophrenia and smoking: an epidemiological survery in a state hospital, Am J Psychiatry, 152, 453, 10.1176/ajp.152.3.453 Evans, 1980, A family and population study of the genetic polymorphism of debrisoquin oxidation in a white British population, J Med Genet, 17, 102, 10.1136/jmg.17.2.102 Pollock, 1995, Prospective cytochrome P450 phenotyping for neuroleptic treatment in dementia, Psychopharmacol Bull, 31, 327 Gilbert, 1995, Neuroleptic withdrawal in schizophrenic patients, Arch Gen Psychiatry, 52, 173, 10.1001/archpsyc.1995.03950150005001 Kuhs, 1995, Suspension therapy in acute schizophrenia, Neuropsychobiology, 31, 135, 10.1159/000119184 Handal, 1995, Antipsychotic agents and pregnant women. A case report, Tidsskr Nor Laegeforen, 115, 2539 Markowitz, 1995, Interactions between antipsychotic and antihypertensive drugs, Ann Pharmacother, 29, 603, 10.1177/106002809502900610 Goff, 1995, A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia, Psychopharmacology, 117, 417, 10.1007/BF02246213 Yasui, 1995, Inhibition of trazodone metabolism by thioridazine in humans, Ther Drug Monit, 17, 333, 10.1097/00007691-199508000-00003 Irvin, 1995, Identification of potential problems for elderly outpatients after preoperative medication: a case study, J Post Anesth Nurs, 10, 159 Day, 1995, A self-rating scale for measuring neuroleptic side-effects, Br J Psychiatry, 166, 650, 10.1192/bjp.166.5.650 Levinson, 1995, Fluphenazine plasma levels, dosage, efficacy, and side effects, Am J Psychiatry, 152, 765, 10.1176/ajp.152.5.765 Darby, 1995, Haloperidol dose and blood level variability: toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting, J Clin Psychopharmacol, 15, 334, 10.1097/00004714-199510000-00005 Toren, 1995, Case study: emergence of transient compulsive symptoms during treatment with clothiapine, J Am Acad Child Adolesc Psychiatry, 34, 1469, 10.1097/00004583-199511000-00013 Buchanan, 1995, Clozapine: efficacy and safety, Schizophr Bull, 21, 579, 10.1093/schbul/21.4.579 Love, 1995, Clozapine use in an Oregon state psychiatric hospital, Am J Health-Syst Pharma, 52, 508, 10.1093/ajhp/52.5.508 Pitner, 1995, Efficacy and adverse effects of clozapine in four elderly psychotic patients, J Clin Psychiatry, 56, 180 Rabey, 1995, Low dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease, Neurology, 45, 432, 10.1212/WNL.45.3.432 Clardy, 1995, Mortality risk and clozapine, Am J Psychiatry, 152, 651, 10.1176/ajp.152.4.651a Lilleng, 1995, Clozapine and myocarditis, Tidsskr Nor Laegeforen, 115, 3026 Diederich, 1995, La clozapine dans le traitement des manifestations psychiatriques de la maladie de Parkinson, Rev Neurol, 151, 251 Aronowitz, 1995, Clozapine and new-onset ECG abnormalities, Psychosomatics, 36, 82, 10.1016/S0033-3182(95)71716-9 Taylor, 1995, Clozapine-induced hypotension treated with moclobemide and Bovril, Br J Psychiatry, 167, 409, 10.1192/bjp.167.3.409 Kurz, 1995, Extrapyramidal side effects of clozapine and haloperidol, Psychopharmacology, 118, 52, 10.1007/BF02245249 Ghaemi, 1995, Is there a relationship between clozapine and obsessive-compulsive disorder? A retrospective chart review, Compr Psychiatry, 36, 267, 10.1016/S0010-440X(95)90071-3 Lindenmayer, 1995, Tic-like syndrome after treatment with clozapine, Am J Psychiatry, 152, 649, 10.1176/ajp.152.4.649 Bak, 1995, Myoclonus in patients treated with clozapine: a case series, J Clin Psychiatry, 56, 418 Worrall, 1995, Dystonia and drug-induced hepatitis in a patient treated with clozapine, Am J Psychiatry, 152, 647, 10.1176/ajp.152.4.647b Tsai, 1995, Neuroleptic malignant syndrome associated with clozapine treatment, Ann Clin Psychiatry, 7, 91, 10.3109/10401239509149033 Lowy, 1995, Disseminated intravascular coagulopathy and thrombocytopenia associated with clozapine-induced neuroleptic malignant syndrome, Aust NZ J Med, 25, 368, 10.1111/j.1445-5994.1995.tb01907.x Sachdev, 1995, Clozapine-induced neuroleptic malignant syndrome: review and report of new cases, J Clin Psychopharmacol, 15, 365, 10.1097/00004714-199510000-00010 Kirson, 1995, Severe elevations in serum creatine kinase associated with clozapine, J Clin Psychopharmacol, 15, 287, 10.1097/00004714-199508000-00011 Nitenson, 1995, Fever associated with clozapine administration, Am J Psychiatry, 152, 1102, 10.1176/ajp.152.7.1102c Lamberti, 1995, Filgrastim treatment of three patients with clozapine-induced agranulocytosis, J Clin Psychiatry, 56, 256 Yunis, 1995, HLA associations in clozapine-induced agranulocytosis, Blood, 86, 1177, 10.1182/blood.V86.3.1177.1177 Popli, 1995, Clozapine and leukocytosis, J Clin Psychopharmacol, 15, 286, 10.1097/00004714-199508000-00010 Thatcher, 1995, Clozapine-induced toxic hepatitis, Am J Psychiatry, 152, 296, 10.1176/ajp.152.2.296b Vasile, 1995, Clozapine and the development of salivary gland swelling: a case study, J Clin Psychiatry, 56, 511 Robinson, 1995, Possible association of parotitis with clozapine, Am J Psychiatry, 152, 297, 10.1176/ajp.152.2.297 Fritze, 1995, Pirenzepine for clozapine-induced hypersalivation, Lancet, 346, 1034, 10.1016/S0140-6736(95)91713-6 Corrigan, 1995, Clozapine-induced hypersalivation and the α2 adrenoceptor, Br J Psychiatry, 167, 412, 10.1192/bjp.167.3.412a Friedberg, 1995, Clozapine-caused eosinophilic colitis, Ann Clin Psychiatry, 7, 97, 10.3109/10401239509149034 Hayes, 1995, Clozapine-induced constipation, Am J Psychiatry, 152, 298, 10.1176/ajp.152.2.298a Erickson, 1995, Clozapine-associated postoperative ileus: case report and review of the literature, Arch Gen Psychiatry, 52, 508, 10.1001/archpsyc.1995.03950180094013 Aronowitz, 1995, Management of clozapine-induced enuresis, Am J Psychiatry, 152, 472, 10.1176/ajp.152.3.472a Howanitz, 1995, Photosensitivity to clozapine, J Clin Psychiatry, 56, 589 Zaluska, 1995, Agranulocytoza w trakcie stosowania kozapiny, Psychiatr Pol, 29, 67 Jackson, 1995, Delirium associated with clozapine and benzodiazepine combinations, Ann Clin Psychiatry, 7, 139, 10.3109/10401239509149041 Carrillo, 1995, Comments to ‘Interaction between caffeine and clozapine’, J Clin Psychopharmacol, 15, 376, 10.1097/00004714-199510000-00015 Kingsbury, 1995, Effects of fluoxetine on serum clozapine levels, Am J Psychiatry, 152, 473, 10.1176/ajp.152.3.473 Baldessarini, 1995, Baldessarini and colleagues reply, Am J Psychiatry, 152, 473, 10.1176/ajp.152.3.473-a Adityanjee, 1995, Modification of clozapine-induced leukopenia and neutropenia with lithium carbonate, Am J Psychiatry, 152, 648, 10.1176/ajp.152.4.648 Costello, 1995, A clinically significant interaction between clozapine and valproate, J Clin Psychopharmacol, 15, 139, 10.1097/00004714-199504000-00011 Shaw, 1995, Postoperative neuroleptic malignant syndrome, Anaesthesia, 50, 246, 10.1111/j.1365-2044.1995.tb04566.x Curtis, 1995, A risk-benefit assessment of risperidone in schizophrenia, Drug Saf, 12, 139, 10.2165/00002018-199512020-00006 Borinson, 1995, Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics, J Clin Psychopharmacol, 15, 24, 10.1097/00004714-199502001-00005 Peuskens, 1995, Risperidone in the treatment of patients with chronic schizophrenia: a multi-nacional, multi-centre, double-blind, parallel-group study versus haloperidol, Br J Psychiatry, 166, 712, 10.1192/bjp.166.6.712 Lindström, 1995, Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia, Clin Ther, 17, 402, 10.1016/0149-2918(95)80105-7 Klieser, 1995, Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia, J Clin Psychopharmacol, 15, 45, 10.1097/00004714-199502001-00008 Lombroso, 1995, Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report, J Am Acad Child Adolesc Psychiatry, 34, 1147, 10.1097/00004583-199509000-00011 Quintana, 1995, Case study: risperidone in children and adolescents with schizophrenia, J Am Acad Child Adolesc Psychiatry, 34, 1292, 10.1097/00004583-199510000-00014 Madhusoodanan, 1995, Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series, J Clin Psychiatry, 56, 514 Rich, 1995, Risperidone versus clozapine in the treatment of psychosis in six patients with parkinson's disease and other akineticprigid syndromes, J Clin Psychiatry, 56, 556 McKeith, 1995, Neuroleptic sensitivity to risperidone in Lewy body dementia, Lancet, 346, 699, 10.1016/S0140-6736(95)92307-1 Mahmood, 1995, Risperidone-induced extrapyramidal reactions, Lancet, 346, 1226, 10.1016/S0140-6736(95)92928-2 Carter, 1995, Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications, Psychopharmacol Bull, 31, 719 Kapur, 1995, The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a pet study, Life Sci, 57, 103, 10.1016/0024-3205(95)02037-J Dave, 1995, Two cases of risperidone-induced neuroleptic malignant syndrome, Am J Psychiatry, 152, 1233, 10.1176/ajp.152.8.1233b Najara, 1995, Risperidone and neuroleptic malignant syndrome: a case report, J Clin Psychiatry, 56, 534 Murray, 1995, Risperidone and NMS?, Psych Serv, 46, 951, 10.1176/ps.46.9.951a Swanson, 1995, Effects of concomitant risperidone and lithium treatment, Am J Psychiatry, 152, 1096, 10.1176/ajp.152.7.1096a Radford, 1995, Unexpected dystonia while changing from clozapine to risperidone, J Clin Psychopharmacol, 15, 225, 10.1097/00004714-199506000-00015 Addington, 1995, Risperidone and tardive dyskinesia: a case report, J Clin Psychiatry, 56, 484 O'Croinin, 1995, Hypomania associated with risperidone, Can J Psychiatry, 40, 51, 10.1177/070674379504000117 Byerly, 1995, Behavioral stimulation associated with risperidone initiation, Am J Psychiatry, 152, 1096, 10.1176/ajp.152.7.1096b Dickson, 1995, Risperidone-induced prolactin elevations in premenopausal women with schizophrenia, Am J Psychiatry, 152, 1102, 10.1176/ajp.152.7.1102b Tekell, 1995, Prolonged erection associated with risperidone treatment, Am J Psychiatry, 152, 1097, 10.1176/ajp.152.7.1097a Cooney, 1995, Angio-oedema associated with risperidone, Br Med J, 310, 1204, 10.1136/bmj.311.7014.1204c Gupta, 1995, Cautions in the clozapine-to-risperidone switch, Ann Clin Psychiatry, 7, 149, 10.3109/10401239509149043